Interferons (IFNs) are cytokines that have a complex and central role in the resistance of mammalian hosts to pathogens. IFN-g, also known as immune or type II IFN, is a homodimer produced predominantly by activated T cells and natural killer (NK) cells, and it is crucial for innate and adaptive immunity against intracellular pathogens and for tumor control. 1,2 Aberrant IFN-g expression is associated with a number of autoinflammatory and autoimmune diseases. The importance of IFN-g in the immune system stems in part from its ability to inhibit viral replication directly, however, most importantly, IFN-g possesses immunostimulatory and immunomodulatory effects. 3, 4 Lactarius hatsudake, belonging to the family Russulaceae of Basidiomycete, is a common edible mushroom widely distributed in Korea, China, Japan, Europe and North America, and biological activity (for example, antitumor and antiviral effects) of L. hatsudake has been reported. 5 Previous investigation on the bioactive constituents of L. hatsudake resulted in the isolation of several ergosterol derivatives 6 and azulene pigments. 7 During the investigation of novel bioactive metabolites from L. hatsudake, we identified two new guaiane sesquiterpenes, lactariolines A (1) and B (2) (Figure 1) , along with four known related compounds, 4-methyl-7-isopropylazulene-1-carboxylic acid (3), 1-formyl-4-methyl-7-isopropyl azulene (4), lactaroviolin (5) and 1-formyl-4-methyl-7-(1-hydroxy-1-methylethyl) azulene (6). 8, 9 In this study, we describe the isolation, structure elucidation and biological activity of two new compounds.
The fruiting bodies of L. hatsudake (6 kg) provided by the National Agrobiodiversity Center (Suwon, Korea) in July 2009 were extracted three times with MeOH at room temperature over 3 days (for each extraction step). The combined MeOH solution was concentrated under reduced pressure to produce a residue (240 g), which was suspended in H 2 O and successively partitioned with n-hexane, EtOAc and n-BuOH. The n-hexane layer (17 g) was loaded on a silica gel column and eluted with CH 2 Cl 2 -MeOH in a gradient mode (20:1-1:1) to yield nine fractions (LH1-9). The fraction LH2 (1.5 g) was applied to a Lichroprep RP-18 column (Merck Ltd, Seoul, Korea) and eluted with MeOH-H 2 O (3:1-1:0) to give three fractions (LH21-23), and the fraction LH21 was subjected to Sephadex LH-20 column (GE Healthcare Bio-Sciences, Uppsala, Sweden) chromatography and eluted with MeOH to afford 4 (12 mg) and 5 (5 mg). The fraction LH5 (1.8 g) was subjected to Sephadex LH-20 column chromatography and eluted with CH 2 Cl 2 -MeOH (1:1) to give four fractions (LH51-54), and the subfraction LH52 was further separated by preparative HPLC on a YMC-Pack ODS column (20Â250 mm, MeOH-H 2 O¼7:3, flow rate¼4 ml min À1 , detection at 254 nm; YMC Co Ltd, Kyoto, Japan) to afford 1 (4 mg, t R ¼28 min) and 2 (3 mg, t R ¼35 min). The fraction LH53 was purified by a Sephadex LH-20 column eluting with 70% MeOH to yield 3 (2 mg). The fraction LH8 (300 mg) was further purified by preparative HPLC (MeOH-H 2 O¼4:1) to afford 6 (15 mg, t R ¼18 min). . The 13 C NMR spectrum of 1 showed 15 carbon signals including one carbonyl group, five quaternary aromatic carbons, five olefinic methines, one oxygenated methylene, two methyl groups and one methoxy group. These spectral data suggest that 1 possessed a structure similar to that of 7-acetyl-4-methylazulene-1-carbaldehyde, a known guaiane sesquiterpene, 11 and the gross structure was confirmed by HMBC experiments ( Table 1 ). In the HMBC spectrum of 1, the methylene group was longrange coupled to C-1 at d C 135.0, C-2 at d C 137.2 and C-9 at d C 132.9 indicating that the oxygenated methylene group was located at C-1. The acetyl group was assigned at C-7 by the HMBC correlations of H-12 with C-7 at d C 129.5 and C-11 at d C 199.1. In addition, HMBC correlations of H-14 with C-4 at d C 150.9, C-5 at d C 125.7 and C-10 at d C 138.5 were observed. Therefore, the structure of 1 was elucidated as 7-acetyl-4-methyl-1-methoxymethyl azulene, and the compound was named 'lactariolines A' .
Compound , H-3) . Its 13 C NMR spectrum showed 16 carbon resonances consisting of one carbonyl group, five quaternary aromatic carbons, five olefinic methines, one quaternary aliphatic carbon, three methyl groups and one methoxy group. The above-mentioned spectral data suggest that 2 had the same gross structure as an analogue, 7-(1-hydroxy-1-methylethyl)-4-methylazulene-1-carbaldehyde, 9 except for the presence of an additional methoxy group at d H 3.17 (3H, s) and d C 51.1. The observed HMBC correlation between the methoxy group and C-11 at d C 79.1 indicated the location of the methoxy group was at C-11. Thus, the structure of 2 was elucidated as 1-formyl-4-methyl-7-(1-methoxy-1-methylethyl) azulene, and the compound was named 'lactariolines B' .
Compounds 1 and 2 were evaluated for their effects on the modulation of IFN-g in NK92 cells. The interleukin (IL)-2-dependent NK cell line NK92 (human NK lymphoma) was obtained from the American Type Culture Collection. NK92 cells were maintained in a-MEM (Life Technologies, Karlsruhe, Germany) containing 20% fetal calf serum (HyClone, Logan, UT, USA), 2 mM L-glutamate, 100 mg ml À1 penicillin, 100 mg ml À1 streptomycin (Life Technologies) and supplemented with 100 U ml À1 IL-2 (Chiron, Emeryville, CA, USA). NK92 cell culture was performed at 37 1C in 5% CO 2 -humidified atmosphere. Quantification of human IFN-g was performed according to the supplier's protocol, using commercially available mAb pairs (Endogen, Woburn, MA, USA). Cell-free supernatants were collected after 18 h of incubation at 37 1C. Figure 2 , compound 1 inhibited IFN-g production in NK92 cells in a dose-dependent manner, corresponding to 56.7% inhibition at 400 mM and 21.4% at 100 mM, respectively. Compound 2 also showed a dose-dependent effect, with 80.9% inhibition at 400 mM and 31.2% at 100 mM. The WST-1 cell proliferation assay showed that no cytotoxicity was observed in the NK92 cells with both cell density up to a concentration of 400 mM. Figure 2 The results of ELISA for IFN-g evaluation in compounds 1 (a) and 2 (b)-treated NK92 cells and cytotoxicity. NK92 cells were cultured in DMEM medium containing 20% FCS and IL-2. For evaluation of the released IFN-g, the washed 5.0Â10 5 cell per ml was distributed into 48-well culture plates. The modulation of IFN-g was assayed by ELISA method with culture supernatant in compounds 1-and 2-treated cells. As negative control (NC) and positive control (PC) was used released IFN-g in the culture supernatant originated from culture medium only and culture medium containing 100 ng of PMA treated cell, respectively. For evaluation of cell viability, we distributed 2.5Â10 3 cell per well into 96-well plates. The WST-1 cell proliferation assay was carried out in compounds 1-and 2-treated cells with dose-dependent manner.
